Alpha 2.0
Login Register
» Authors » S C Raimondi

S C Raimondi

Explore the profile of S C Raimondi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 188
Citations 3585
Followers 0
Related Specialties
Hematology
Oncology
General Medicine
Top 10 Co-Authors
F G Behm
C H Pui
G K Rivera
R C Ribeiro
W M Crist
J T Sandlund
J E Rubnitz
D L Williams
A J Carroll
D Campana
Published In
Leukemia
Blood
J Clin Oncol
Cancer Genet Cytogenet
Lancet
Affiliations
Soon will be listed here.
Recent Articles
1.
Germline SAMD9 mutation in siblings with monosomy 7 and myelodysplastic syndrome
Schwartz J, Wang S, Ma J, Lamprecht T, Walsh M, Song G, et al.
Leukemia . 2017 May; 31(8):1827-1830. PMID: 28487541
No abstract available.
2.
Clinical impact of minimal residual disease in children with different subtypes of acute lymphoblastic leukemia treated with Response-Adapted therapy
Pui C, Pei D, Raimondi S, Coustan-Smith E, Jeha S, Cheng C, et al.
Leukemia . 2016 Aug; 31(2):333-339. PMID: 27560110
To determine the clinical significance of minimal residual disease (MRD) in patients with prognostically relevant subtypes of childhood acute lymphoblastic leukemia (ALL), we analyzed data from 488 patients treated in...
3.
Ethnic variation of TET2 SNP rs2454206 and association with clinical outcome in childhood AML: a report from the Children's Oncology Group
Kutny M, Alonzo T, Gamazon E, Gerbing R, Geraghty D, Lange B, et al.
Leukemia . 2015 Jul; 29(12):2424-6. PMID: 26126966
No abstract available.
4.
A revised definition for cure of childhood acute lymphoblastic leukemia
Pui C, Pei D, Campana D, Cheng C, Sandlund J, Bowman W, et al.
Leukemia . 2014 May; 28(12):2336-43. PMID: 24781017
With improved contemporary therapy, we reassess long-term outcome in patients completing treatment for childhood acute lymphoblastic leukemia (ALL) to determine when cure can be declared with a high degree of...
5.
An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome
Harrison C, Moorman A, Schwab C, Carroll A, Raetz E, Devidas M, et al.
Leukemia . 2013 Oct; 28(5):1015-21. PMID: 24166298
Intrachromosomal amplification of chromosome 21 (iAMP21) defines a distinct cytogenetic subgroup of childhood B-cell precursor acute lymphoblastic leukaemia (BCP-ALL). To date, fluorescence in situ hybridisation (FISH), with probes specific for...
6.
Prognostic features in acute megakaryoblastic leukemia in children without Down syndrome: a report from the AML02 multicenter trial and the Children's Oncology Group Study POG 9421
OBrien M, Cao X, Pounds S, Dahl G, Raimondi S, Lacayo N, et al.
Leukemia . 2012 Aug; 27(3):731-4. PMID: 22918081
No abstract available.
7.
ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with contemporary therapy
Bhojwani D, Pei D, Sandlund J, Jeha S, Ribeiro R, Rubnitz J, et al.
Leukemia . 2011 Aug; 26(2):265-70. PMID: 21869842
ETV6-RUNX1 fusion is the most common genetic aberration in childhood acute lymphoblastic leukemia (ALL). To evaluate whether outcomes for this drug-sensitive leukemia are improved by contemporary risk-directed therapy, we studied...
8.
IDH1 and IDH2 mutations in pediatric acute leukemia
Andersson A, Miller D, Lynch J, Lemoff A, Cai Z, Pounds S, et al.
Leukemia . 2011 Jun; 25(10):1570-7. PMID: 21647154
To investigate the frequency of isocitrate dehydrogenase 1 (IDH1) and 2 (IDH2) mutations in pediatric acute myeloid leukemia (AML) and acute lymphoid leukemia (ALL), we sequenced these genes in diagnostic...
9.
Prevalence and clinical implications of NRAS mutations in childhood AML: a report from the Children's Oncology Group
Berman J, Gerbing R, Alonzo T, Ho P, Miller K, HURWITZ C, et al.
Leukemia . 2011 Mar; 25(6):1039-42. PMID: 21358716
No abstract available.
10.
Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group study
Ho P, Alonzo T, Kopecky K, Miller K, Kuhn J, Zeng R, et al.
Leukemia . 2010 Apr; 24(5):909-13. PMID: 20376086
Recent whole-genome sequencing efforts led to the identification of IDH1(R132) mutations in acute myeloid leukemia (AML) patients. We studied the prevalence and clinical implications of IDH1 genomic alterations in pediatric...